Analystreport

Cancer Genetics, Inc. (NASDAQ: CGIX) is now covered by analysts at Dawson James. They set a "buy" rating on the stock.

CANCER GENETICS  (CGIX) 
Last cancer genetics earnings: 11/19 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cancergenetics.com